Search

Drug Profiles Catalysts Company Profiles Impact Events Target
Indication Trials KOL Insight Special Reports All

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
07/31/14 Baxter (BAX) HyQvia for Primary Immunodeficiencies Subscribers Only Subscribers Only     Subscribers Only
07/31/14 Novartis (NVS) Arzerra for Chronic Lymphocytic Leukemia (CLL)/Small Cell Lymphocytic Lymphoma (SLL) - NHL Subscribers Only Subscribers Only     Subscribers Only
07/31/14 Boehringer Striverdi Respimat for Chronic Obstructive Pulmonary Disease (COPD) Subscribers Only Subscribers Only     Subscribers Only
07/31/14 CytoDyn (CYDY) PRO 140 for HIV / AIDS Subscribers Only Subscribers Only     Subscribers Only
07/31/14 Eisai (ESALY) Lenvatinib for Thyroid Cancer Subscribers Only Subscribers Only     Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
08/01/14 Subscribers Only Subscribers Only Company - Earnings Announcement
08/01/14 Subscribers Only Subscribers Only Company - Earnings Announcement
08/01/14 Subscribers Only Subscribers Only Trial Data - Top-Line Results
08/01/14 Subscribers Only Subscribers Only Company - Earnings Announcement
08/01/14 Subscribers Only Subscribers Only Company - Earnings Announcement